En undersøgelse af Izalontamab Brengitecan versus kemoterapi hos deltagere med tidligere ubehandlet, lokalt avanceret, tilbagevendende inoperable eller metastatiske triple-negative brystkræft, der ikke var berettiget til anti-PD (L) 1 lægemidler (izabright-breast01)
En randomiseret, åben mærket, inferentielt sømløs fase 2/3 undersøgelse af Izalontamab Brengitecan (BMS-986507) versus behandling af lægens valg hos patienter med tidligere ubehandlet, lokalt avanceret, tilbagevendende inoperable eller metastatiske triple-negative brystkræft (TNBC) eller ER-LOW, hendes2-negative bc, som er inlig for i henhold til foreløbt for brystkræft Anti-PD1/PD-L1-behandling
The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physician's choice (TPC) (paclitaxel, nab-paclitaxel, carboplatin plus gemcitabine, and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative BC patients who are not candidates for anti-PD(L)1 therapy and endocrine therapies.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Fase 2
- Fase 3
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: First line of the email MUST contain NCT # and Site #.
Undersøgelse Kontakt Backup
- Navn: BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
- Telefonnummer: 855-907-3286
- E-mail: Clinical.Trials@bms.com
Studiesteder
-
-
-
Buenos Aires, Argentina, 1430
- Ikke rekrutterer endnu
- Local Institution - 0346
-
Kontakt:
- Site 0346
-
Buenos Aires, Argentina, 1122
- Afsluttet
- Local Institution - 0345
-
Buenos Aires, Argentina, 1426
- Aktiv, ikke rekrutterende
- Local Institution - 0012
-
Buenos Aires, Argentina, 1426
- Aktiv, ikke rekrutterende
- Local Institution - 0317
-
Mendoza, Argentina, 5500
- Afsluttet
- Local Institution - 0348
-
-
Buenos Aires
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 1280
- Ikke rekrutterer endnu
- Local Institution - 0011
-
Kontakt:
- Site 0011
-
-
Buenos Aires F.D.
-
ABB, Buenos Aires F.D., Argentina, 1181
- Afsluttet
- Local Institution - 0214
-
-
Córdoba Province
-
Córdoba, Córdoba Province, Argentina, X5004BAL
- Aktiv, ikke rekrutterende
- Local Institution - 0143
-
Río Cuarto, Córdoba Province, Argentina, X5800ALB
- Aktiv, ikke rekrutterende
- Local Institution - 0137
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentina, 2000
- Aktiv, ikke rekrutterende
- Local Institution - 0142
-
-
-
-
New South Wales
-
Macquarie University, New South Wales, Australien, 2109
- Aktiv, ikke rekrutterende
- Local Institution - 0170
-
-
Queensland
-
Brisbane, Queensland, Australien, 4029
- Aktiv, ikke rekrutterende
- Local Institution - 0035
-
-
Victoria
-
Ballarat Central, Victoria, Australien, 3350
- Aktiv, ikke rekrutterende
- Local Institution - 0197
-
Heidelberg, Victoria, Australien, 3084
- Aktiv, ikke rekrutterende
- Local Institution - 0031
-
Melbourne, Victoria, Australien, 3000
- Aktiv, ikke rekrutterende
- Local Institution - 0274
-
-
Western Australia
-
Subiaco, Western Australia, Australien, 6008
- Afsluttet
- Local Institution - 0028
-
-
-
-
-
Rio de Janeiro, Brasilien, 20230-130
- Aktiv, ikke rekrutterende
- Local Institution - 0153
-
São Paulo, Brasilien, 01317-000
- Aktiv, ikke rekrutterende
- Local Institution - 0144
-
São Paulo, Brasilien, 01401-002
- Aktiv, ikke rekrutterende
- Local Institution - 0149
-
-
Amazonas
-
Manaus, Amazonas, Brasilien, 69020-030
- Trukket tilbage
- Local Institution - 0187
-
-
Ceará
-
Fortaleza, Ceará, Brasilien, 60135-237
- Aktiv, ikke rekrutterende
- Local Institution - 0147
-
-
Espírito Santo
-
Vitória, Espírito Santo, Brasilien, 29055450
- Afsluttet
- Local Institution - 0157
-
-
Federal District
-
Lago Sul, Federal District, Brasilien, 71681-603
- Trukket tilbage
- Local Institution - 1038
-
-
Paraná
-
Curitiba, Paraná, Brasilien, 81480-580
- Afsluttet
- Local Institution - 0159
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasilien, 90470-340
- Afsluttet
- Local Institution - 0199
-
-
São Paulo
-
Barretos, São Paulo, Brasilien, 14784400
- Aktiv, ikke rekrutterende
- Local Institution - 0148
-
São José do Rio Preto, São Paulo, Brasilien, 15090000
- Aktiv, ikke rekrutterende
- Local Institution - 0164
-
-
-
-
British Columbia
-
Kelowna, British Columbia, Canada, V1Y 5L3
- Rekruttering
- BC Cancer Kelowna
-
Kontakt:
- Susan Ellard, Site 0218
- Telefonnummer: +1250-712-3996
-
Victoria, British Columbia, Canada, V8R 6V5
- Trukket tilbage
- Local Institution - 0217
-
-
Ontario
-
Ottawa, Ontario, Canada, K1H 8L6
- Rekruttering
- The Ottawa Hospital - General Campus
-
Kontakt:
- Xinni Song, Site 0265
- Telefonnummer: 6137377700ext70208
-
-
Quebec
-
Montreal, Quebec, Canada, H4A 3J1
- Rekruttering
- McGill University Health Centre
-
Kontakt:
- Jamil Asselah, Site 0219
- Telefonnummer: 514934193435721
-
Montreal, Quebec, Canada, H2X 3E4
- Rekruttering
- Centre Hospitalier de l'Université de Montréal
-
Kontakt:
- Danielle Charpentier, Site 0215
- Telefonnummer: 5148908000
-
Saint-Charles-Borromée, Quebec, Canada, J6E 6J2
- Rekruttering
- Centre Intégré de Santé et de Services Sociaux de Lanaudière
-
Kontakt:
- Angélique Brunot, Site 0350
- Telefonnummer: 579-593-1172
-
Sherbrooke, Quebec, Canada, J1H 5N4
- Rekruttering
- Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUS
-
Kontakt:
- Michel Pavic, Site 0216
- Telefonnummer: 819-346-1110x74816
-
-
-
-
Santiago Metropolitan
-
Santiago, Santiago Metropolitan, Chile, 7500921
- Afsluttet
- Local Institution - 0138
-
Santiago, Santiago Metropolitan, Chile, 7650568
- Aktiv, ikke rekrutterende
- Local Institution - 0021
-
Santiago, Santiago Metropolitan, Chile, 8330032
- Aktiv, ikke rekrutterende
- Local Institution - 0017
-
Santiago, Santiago Metropolitan, Chile, 8420383
- Aktiv, ikke rekrutterende
- Local Institution - 0018
-
-
Valparaiso
-
Viña del Mar, Valparaiso, Chile, 2520598
- Afsluttet
- Local Institution - 0016
-
-
-
-
-
Medellín, Colombia, 050030
- Ikke rekrutterer endnu
- Local Institution - 0349
-
Kontakt:
- Site 0349
-
-
Antioquia
-
Medellín, Antioquia, Colombia, 50021
- Trukket tilbage
- Local Institution - 0195
-
Rionegro, Antioquia, Colombia, 054047
- Ikke rekrutterer endnu
- Local Institution - 0201
-
Kontakt:
- Site 0201
-
-
Atlántico
-
Barranquilla, Atlántico, Colombia, 080020
- Ikke rekrutterer endnu
- Local Institution - 0194
-
Kontakt:
- Site 0194
-
Puerto Colombia, Atlántico, Colombia, 81001
- Trukket tilbage
- Local Institution - 0182
-
-
COR
-
Montería, COR, Colombia, 230002
- Ikke rekrutterer endnu
- Local Institution - 0181
-
Kontakt:
- Site 0181
-
-
Cundinamarca
-
Bogota, Cundinamarca, Colombia, 111151
- Ikke rekrutterer endnu
- Local Institution - 0327
-
Kontakt:
- Site 0327
-
-
Valle del Cauca Department
-
Cali, Valle del Cauca Department, Colombia, 760032
- Ikke rekrutterer endnu
- Local Institution - 0183
-
Kontakt:
- Site 0183
-
-
-
-
-
Belfast, Det Forenede Kongerige, BT9 7AB
- Trukket tilbage
- Local Institution - 0171
-
Manchester, Det Forenede Kongerige, M20 4BX
- Aktiv, ikke rekrutterende
- Local Institution - 0001
-
Nottingham, Det Forenede Kongerige, NG5 1PB
- Ikke rekrutterer endnu
- Local Institution - 0006
-
Kontakt:
- Site 0006
-
-
England
-
Truro, England, Det Forenede Kongerige, TR1 3LJ
- Afsluttet
- Local Institution - 0208
-
-
London, City of
-
London, London, City of, Det Forenede Kongerige, SE1 9RT
- Trukket tilbage
- Local Institution - 0204
-
London, London, City of, Det Forenede Kongerige, EC1A 7BE
- Aktiv, ikke rekrutterende
- Local Institution - 0004
-
London, London, City of, Det Forenede Kongerige, SE1 9RT
- Afsluttet
- Local Institution - 0209
-
-
-
-
-
Abu Dhabi, Forenede Arabiske Emirater
- Trukket tilbage
- Local Institution - 0319
-
-
Abu Dhabi Emirate
-
Abu Dhabi, Abu Dhabi Emirate, Forenede Arabiske Emirater, 11001
- Trukket tilbage
- Local Institution - 0323
-
Abu Dhabi, Abu Dhabi Emirate, Forenede Arabiske Emirater, 92510
- Trukket tilbage
- Local Institution - 0318
-
Al Ain City, Abu Dhabi Emirate, Forenede Arabiske Emirater, 15258
- Trukket tilbage
- Local Institution - 0322
-
-
-
-
Arkansas
-
Hot Springs, Arkansas, Forenede Stater, 71913
- Ikke rekrutterer endnu
- Local Institution - 0303
-
Kontakt:
- Site 0303
-
-
California
-
Cerritos, California, Forenede Stater, 90703
- Trukket tilbage
- Local Institution - 0307
-
Cerritos, California, Forenede Stater, 90703
- Trukket tilbage
- Local Institution - 0308
-
Cerritos, California, Forenede Stater, 90703
- Trukket tilbage
- Local Institution - 0309
-
Cerritos, California, Forenede Stater, 90703
- Aktiv, ikke rekrutterende
- Local Institution - 0328
-
Long Beach, California, Forenede Stater, 90805
- Trukket tilbage
- Local Institution - 0311
-
Los Angeles, California, Forenede Stater, 90033
- Afsluttet
- Local Institution - 0290
-
Los Angeles, California, Forenede Stater, 90067
- Afsluttet
- Local Institution - 0283
-
Newport Beach, California, Forenede Stater, 92663
- Afsluttet
- Local Institution - 0353
-
Stanford, California, Forenede Stater, 94305
- Trukket tilbage
- Local Institution - 0358
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80045
- Ikke rekrutterer endnu
- Local Institution - 0289
-
Kontakt:
- Site 0289
-
Denver, Colorado, Forenede Stater, 80220
- Aktiv, ikke rekrutterende
- Local Institution - 0367
-
-
Delaware
-
Newark, Delaware, Forenede Stater, 19713
- Afsluttet
- Local Institution - 0304
-
-
Florida
-
Pembroke Pines, Florida, Forenede Stater, 33028
- Trukket tilbage
- Local Institution - 0296
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30322
- Afsluttet
- Local Institution - 0294
-
Atlanta, Georgia, Forenede Stater, 30342
- Afsluttet
- Local Institution - 0357
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60637
- Ikke rekrutterer endnu
- Local Institution - 0280
-
Kontakt:
- Site 0280
-
Chicago, Illinois, Forenede Stater, 60612
- Trukket tilbage
- Local Institution - 0278
-
Decatur, Illinois, Forenede Stater, 62526
- Afsluttet
- Local Institution - 0275
-
O'Fallon, Illinois, Forenede Stater, 62269
- Trukket tilbage
- Local Institution - 0324
-
-
Louisiana
-
Covington, Louisiana, Forenede Stater, 70433
- Afsluttet
- Local Institution - 0286
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21201
- Trukket tilbage
- Local Institution - 1035
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02114
- Afsluttet
- Local Institution - 0288
-
Boston, Massachusetts, Forenede Stater, 02215
- Aktiv, ikke rekrutterende
- Local Institution - 0287
-
-
Michigan
-
Detroit, Michigan, Forenede Stater, 48202
- Afsluttet
- Local Institution - 0359
-
-
Minnesota
-
Maple Grove, Minnesota, Forenede Stater, 55369
- Afsluttet
- Local Institution - 0313
-
Minneapolis, Minnesota, Forenede Stater, 55455
- Trukket tilbage
- Local Institution - 0372
-
-
Missouri
-
Kansas City, Missouri, Forenede Stater, 64111
- Afsluttet
- Local Institution - 0284
-
-
New York
-
New York, New York, Forenede Stater, 10016
- Trukket tilbage
- Local Institution - 0312
-
New York, New York, Forenede Stater, 10065
- Afsluttet
- Local Institution - 0279
-
Syracuse, New York, Forenede Stater, 13210
- Trukket tilbage
- Local Institution - 1037
-
Westbury, New York, Forenede Stater, 11590
- Afsluttet
- Local Institution - 0295
-
White Plains, New York, Forenede Stater, 10601
- Afsluttet
- Local Institution - 0285
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27710
- Afsluttet
- Local Institution - 0276
-
-
Oregon
-
Eugene, Oregon, Forenede Stater, 97401
- Afsluttet
- Local Institution - 0316
-
-
Pennsylvania
-
Allentown, Pennsylvania, Forenede Stater, 18103
- Aktiv, ikke rekrutterende
- Local Institution - 0356
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Afsluttet
- Local Institution - 0310
-
Pittsburgh, Pennsylvania, Forenede Stater, 15213-3403
- Trukket tilbage
- Local Institution - 0360
-
-
South Carolina
-
Greenville, South Carolina, Forenede Stater, 29607
- Afsluttet
- Local Institution - 0281
-
-
Texas
-
Austin, Texas, Forenede Stater, 78705
- Afsluttet
- Local Institution - 0315
-
El Paso, Texas, Forenede Stater, 79902
- Afsluttet
- Local Institution - 0368
-
Flower Mound, Texas, Forenede Stater, 75028
- Aktiv, ikke rekrutterende
- Local Institution - 0305
-
Houston, Texas, Forenede Stater, 77024-2843
- Afsluttet
- Local Institution - 0314
-
-
Virginia
-
Midlothian, Virginia, Forenede Stater, 23114
- Aktiv, ikke rekrutterende
- Local Institution - 0277
-
Roanoke, Virginia, Forenede Stater, 24014
- Ikke rekrutterer endnu
- Local Institution - 0301
-
Kontakt:
- Site 0301
-
Winchester, Virginia, Forenede Stater, 22601
- Aktiv, ikke rekrutterende
- Local Institution - 0302
-
-
-
-
-
Lille, Frankrig, 59000
- Afsluttet
- Local Institution - 0094
-
Paris, Frankrig, 75248
- Trukket tilbage
- Local Institution - 0088
-
-
Aquitaine
-
Bordeaux, Aquitaine, Frankrig, 33076
- Aktiv, ikke rekrutterende
- Local Institution - 0089
-
-
Auvergne-Rhône-Alpes
-
Lyon, Auvergne-Rhône-Alpes, Frankrig, 69008
- Trukket tilbage
- Local Institution - 0090
-
-
Côte-d'Or
-
Dijon, Côte-d'Or, Frankrig, 21079
- Afsluttet
- Local Institution - 0272
-
-
Haute-Garonne
-
Toulouse, Haute-Garonne, Frankrig, 31059
- Trukket tilbage
- Local Institution - 0098
-
-
Hérault
-
Montpellier, Hérault, Frankrig, 34298
- Rekruttering
- Institut Régional du Cancer Montpellier
-
Kontakt:
- Marie Alexandre, Site 0095
- Telefonnummer: 33467612393
-
-
Ille-et-Vilaine
-
Rennes, Ille-et-Vilaine, Frankrig, 35042
- Afsluttet
- Local Institution - 0099
-
-
Loire-Atlantique
-
Saint-Herblain, Loire-Atlantique, Frankrig, 44805
- Afsluttet
- Local Institution - 0092
-
-
Marne
-
Reims, Marne, Frankrig, 51726
- Trukket tilbage
- Local Institution - 0091
-
-
Paris
-
Villejuif, Paris, Frankrig, 94800
- Aktiv, ikke rekrutterende
- Local Institution - 0097
-
-
Provence-Alpes-Côte d'Azur Region
-
Marseille, Provence-Alpes-Côte d'Azur Region, Frankrig, 13273
- Rekruttering
- Institut Paoli-Calmettes
-
Kontakt:
- Alexandre Tassin de Nonneville, Site 0093
- Telefonnummer: 0033621713044
-
-
Puy-de-Dôme
-
Clermont-Ferrand, Puy-de-Dôme, Frankrig, 63011
- Rekruttering
- Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne
-
Kontakt:
- Olivier Collard, Site 0096
- Telefonnummer: 33473278005
-
-
Vienne
-
Poitiers, Vienne, Frankrig, 86021
- Trukket tilbage
- Local Institution - 1033
-
-
-
-
Attica
-
Athens, Attica, Grækenland, 11528
- Trukket tilbage
- Local Institution - 0043
-
-
Attikí
-
Athens, Attikí, Grækenland, 115 22
- Aktiv, ikke rekrutterende
- Local Institution - 0042
-
Athens, Attikí, Grækenland, 185 47
- Afsluttet
- Local Institution - 0038
-
-
Irakleío
-
Heraklion, Irakleío, Grækenland, 715 00
- Afsluttet
- Local Institution - 0086
-
-
-
-
Maharashtra
-
Mumbai, Maharashtra, Indien, 400 057
- Trukket tilbage
- Local Institution - 0337
-
Mumbai, Maharashtra, Indien, 400012
- Trukket tilbage
- Local Institution - 0131
-
Nagpur, Maharashtra, Indien, 440001
- Trukket tilbage
- Local Institution - 0134
-
-
National Capital Territory of Delhi
-
New Delhi, National Capital Territory of Delhi, Indien, 110017
- Trukket tilbage
- Local Institution - 0352
-
New Delhi, National Capital Territory of Delhi, Indien, 110029
- Trukket tilbage
- Local Institution - 0266
-
New Delhi, National Capital Territory of Delhi, Indien, 110085
- Trukket tilbage
- Local Institution - 0206
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, Indien, 600035
- Trukket tilbage
- Local Institution - 0125
-
-
Telangana
-
Hyderabad, Telangana, Indien, 500082
- Trukket tilbage
- Local Institution - 0130
-
-
Uttar Pradesh
-
Varanasi, Uttar Pradesh, Indien, 221005
- Trukket tilbage
- Local Institution - 0133
-
-
-
-
Central District
-
Petah Tikva, Central District, Israel, 4941492
- Ikke rekrutterer endnu
- Local Institution - 0186
-
Kontakt:
- Site 0186
-
Ramat Gan, Central District, Israel, 5265601
- Aktiv, ikke rekrutterende
- Local Institution - 0044
-
-
Jerusalem
-
Jerusalem, Jerusalem, Israel, 9112001
- Afsluttet
- Local Institution - 0047
-
-
Northern District
-
Hadera, Northern District, Israel, 38100
- Aktiv, ikke rekrutterende
- Local Institution - 0048
-
Haifa, Northern District, Israel, 3109601
- Aktiv, ikke rekrutterende
- Local Institution - 0123
-
-
-
-
-
Milan, Italien, 20141
- Aktiv, ikke rekrutterende
- Local Institution - 0052
-
Naples, Italien, 80131
- Afsluttet
- Local Institution - 0058
-
Novara, Italien, 28100
- Afsluttet
- Local Institution - 0061
-
Padova, Italien, 35128
- Afsluttet
- Local Institution - 0056
-
Roma, Italien, 00168
- Aktiv, ikke rekrutterende
- Local Institution - 0062
-
-
Campania
-
Naples, Campania, Italien, 80131
- Aktiv, ikke rekrutterende
- Local Institution - 0051
-
-
Emilia-Romagna
-
Bologna, Emilia-Romagna, Italien, 40138
- Afsluttet
- Local Institution - 0049
-
-
Friuli Venezia Giulia
-
Aviano, Friuli Venezia Giulia, Italien, 33081
- Aktiv, ikke rekrutterende
- Local Institution - 0057
-
-
Liguria
-
Genoa, Liguria, Italien, 16132
- Afsluttet
- Local Institution - 0054
-
-
Pisa
-
Pontedera, Pisa, Italien, 56025
- Aktiv, ikke rekrutterende
- Local Institution - 0053
-
-
Tuscany
-
Prato, Tuscany, Italien, 59100
- Afsluttet
- Local Institution - 0055
-
-
-
-
-
Fukuoka, Japan, 811-1395
- Trukket tilbage
- Local Institution - 0242
-
Fukushima, Japan, 960-1295
- Trukket tilbage
- Local Institution - 0225
-
Hiroshima, Japan, 7308518
- Trukket tilbage
- Local Institution - 0243
-
Kyoto, Japan, 606-8507
- Trukket tilbage
- Local Institution - 0235
-
Okayama, Japan, 700-8558
- Trukket tilbage
- Local Institution - 0241
-
Osaka, Japan, 541-8567
- Trukket tilbage
- Local Institution - 0239
-
-
Aichi-ken
-
Nagoya, Aichi-ken, Japan, 464-8681
- Trukket tilbage
- Local Institution - 0236
-
-
Chiba
-
Chiba, Chiba, Japan, 260-8717
- Trukket tilbage
- Local Institution - 0230
-
-
Ehime
-
Matsuyama, Ehime, Japan, 791-0280
- Trukket tilbage
- Local Institution - 0240
-
-
Gunma
-
Otashi, Gunma, Japan, 373-8550
- Trukket tilbage
- Local Institution - 0226
-
-
Hokkaido
-
Sapporo, Hokkaido, Japan, 003-0804
- Trukket tilbage
- Local Institution - 0222
-
-
Ishikawa-ken
-
Kanazawa, Ishikawa-ken, Japan, 920-8530
- Trukket tilbage
- Local Institution - 0232
-
-
Kagoshima-ken
-
Kagoshima, Kagoshima-ken, Japan, 892-0833
- Trukket tilbage
- Local Institution - 0244
-
-
Kanagawa
-
Isehara, Kanagawa, Japan, 259-1193
- Trukket tilbage
- Local Institution - 0234
-
Yokohama, Kanagawa, Japan, 2418515
- Trukket tilbage
- Local Institution - 0237
-
-
Mie-ken
-
Tsu, Mie-ken, Japan, 514-8507
- Trukket tilbage
- Local Institution - 0246
-
-
Miyagi
-
Sendai, Miyagi, Japan, 980-8574
- Trukket tilbage
- Local Institution - 0223
-
-
Osaka
-
Suita, Osaka, Japan, 565-0871
- Trukket tilbage
- Local Institution - 0238
-
-
Saitama
-
Hidaka, Saitama, Japan, 350-1298
- Trukket tilbage
- Local Institution - 0227
-
Ina-machi, Saitama, Japan, 362-0806
- Trukket tilbage
- Local Institution - 0224
-
-
Tokyo
-
Bunkyo-ku, Tokyo, Japan, 113-8431
- Trukket tilbage
- Local Institution - 0231
-
Chuo-ku, Tokyo, Japan, 104-0045
- Trukket tilbage
- Local Institution - 0229
-
Koto, Tokyo, Japan, 135-8550
- Trukket tilbage
- Local Institution - 0228
-
Shinagawa-ku, Tokyo, Japan, 142-8666
- Trukket tilbage
- Local Institution - 0245
-
Shinjuku-ku, Tokyo, Japan, 160-0023
- Trukket tilbage
- Local Institution - 0233
-
-
-
-
-
Guangzhou, Kina, 510060
- Rekruttering
- Sun Yat-sen University Cancer Center
-
Kontakt:
- Shusen Wang, Site 1025
- Telefonnummer: 8613926168469
-
-
Anhui
-
Hefei, Anhui, Kina, 230001
- Rekruttering
- Anhui Provincial Hospital
-
Kontakt:
- Nannan Lu, Site 1002
- Telefonnummer: 8618130056850
-
Hefei, Anhui, Kina, 230601
- Rekruttering
- The Second Hospital of Anhui Medical University
-
Kontakt:
- Fanfan Li, Site 1003
- Telefonnummer: +8613855137365
-
-
BEI
-
Beijing, BEI, Kina, 100021
- Rekruttering
- Cancer Hospital Chinese Academy of Medical Sciences
-
Kontakt:
- Binghe Xu, Site 1001
- Telefonnummer: +86 13501028690
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Kina, 100142
- Rekruttering
- Beijing Cancer Hospital
-
Kontakt:
- Huiping Li, Site 1005
- Telefonnummer: 8613811012595
-
Beijing, Beijing Municipality, Kina, 100142
- Rekruttering
- China-Japan Friendship Hospital
-
Kontakt:
- Donggui Wan, Site 1024
- Telefonnummer: 8619854715414
-
-
Fujian
-
Fuzhou, Fujian, Kina, 350000
- Rekruttering
- Fujian Cancer Hospital
-
Kontakt:
- Fan Wu, Site 1006
- Telefonnummer: 8613859082118
-
Fyzhou, Fujian, Kina, 350001
- Rekruttering
- Fujian Medical University Union Hospital
-
Kontakt:
- Fangmeng Fu, Site 1007
- Telefonnummer: 8613365917923
-
Xiamen, Fujian, Kina, 361003
- Trukket tilbage
- Local Institution - 1016
-
-
Gansu
-
Lanzhou, Gansu, Kina, 730000
- Rekruttering
- The First Hospital of Lanzhou University
-
Kontakt:
- Xiaoling Ling, Site 1031
- Telefonnummer: 8618693165668
-
-
Guangxi
-
Nanning, Guangxi, Kina, 530021
- Rekruttering
- Guangxi Medical University Affiliated Cancer Hospital
-
Kontakt:
- Wei Wei, Site 1008
- Telefonnummer: 8618577071966
-
-
HUN
-
Changsha, HUN, Kina, 410013
- Ikke rekrutterer endnu
- Local Institution - 1011
-
Kontakt:
- Site 1011
-
-
Harbin
-
Harbin, Harbin, Kina, 150001
- Rekruttering
- The First Hospital of harbin University
-
Kontakt:
- Li Cai, Site 1028
- Telefonnummer: 8613313602929
-
-
Henan
-
Anyang, Henan, Kina, 455110
- Rekruttering
- Anyang Cancer Hospital
-
Kontakt:
- Junlan Guo, Site 1004
- Telefonnummer: 8615037272967
-
Zhengzhou, Henan, Kina, 450008
- Rekruttering
- Henan Cancer Hospital
-
Kontakt:
- Min Yan, Site 1009
- Telefonnummer: 8615713857388
-
Zhengzhou, Henan, Kina, 450052
- Rekruttering
- The First Affiliated Hospital of Zhengzhou University
-
Kontakt:
- Wei He, Site 1032
- Telefonnummer: +8618638553286
-
-
Hubei
-
Wuhan, Hubei, Kina, 430070
- Rekruttering
- Hubei Cancer Hospital
-
Kontakt:
- Xinhong Wu, Site 1010
- Telefonnummer: 8618602726300
-
Wuhan, Hubei, Kina, 430061
- Rekruttering
- Zhongnan Hospital of Wuhan University
-
Kontakt:
- Haijun Yu, Site 1021
- Telefonnummer: 8613971665181
-
Xiangyang, Hubei, Kina, 441000
- Rekruttering
- Xiangyang Central Hospital
-
Kontakt:
- Yuehua Wang, Site 1022
- Telefonnummer: 8613995777482
-
-
Jiangxi
-
Nanchang, Jiangxi, Kina, 330029
- Rekruttering
- Jiangxi Cancer Hospital
-
Kontakt:
- Zhengkui Sun, Site 1013
- Telefonnummer: 8613907000210
-
-
Liaoning
-
Changchun, Liaoning, Kina, 130021
- Ikke rekrutterer endnu
- Local Institution - 1012
-
Kontakt:
- Site 1012
-
Shenyang, Liaoning, Kina, 140001
- Rekruttering
- Liaoning Cancer Hospital
-
Kontakt:
- Tao Sun, Site 1014
- Telefonnummer: 8613940404526
-
-
Shandong
-
Jinan, Shandong, Kina, 250117
- Rekruttering
- Cancer Hospital of Shandong First Medical University
-
Kontakt:
- Huihui Li, Site 1017
- Telefonnummer: 8615553103209
-
Qingdao, Shandong, Kina, 266071
- Rekruttering
- The Affiliated Hospital Of Qingdao University
-
Kontakt:
- Haibo Wang, Site 1015
- Telefonnummer: 8618661805787
-
-
Shanxi
-
Taiyuan, Shanxi, Kina, 650118
- Rekruttering
- Shanxi Cancer Hospital
-
Kontakt:
- Guohui Han, Site 1018
- Telefonnummer: 8613454858188
-
-
Sichuan
-
Chengdu, Sichuan, Kina, 610072
- Rekruttering
- Sichuan Provincial People'S Hospital
-
Kontakt:
- Jing Luo, Site 1019
- Telefonnummer: 8618981838521
-
-
Tianjin Municipality
-
Tianjin, Tianjin Municipality, Kina, 300060
- Rekruttering
- Tianjin Cancer Hospital Airport Hospital
-
Kontakt:
- Chunfang Hao, Site 1027
- Telefonnummer: 8613602031629
-
Tianjin, Tianjin Municipality, Kina, 301000
- Rekruttering
- Tianjin Medical University Cancer Institute & Hospital
-
Kontakt:
- Yehui Shi, Site 1020
- Telefonnummer: 8618622221183
-
-
Yunnan
-
Kunming, Yunnan, Kina, 650118
- Rekruttering
- Yunnan Cancer Hospital
-
Kontakt:
- Guojun Zhang, Site 1029
- Telefonnummer: 8618850064298
-
-
Zhejiang
-
Hangzhou, Zhejiang, Kina, 310024
- Rekruttering
- The First Affiliated Hospital, Zhejiang University School of Medicine
-
Kontakt:
- Peifen Fu, Site 1023
- Telefonnummer: 8613958161556
-
Hangzhou, Zhejiang, Kina, 310022
- Ikke rekrutterer endnu
- Local Institution - 1040
-
Kontakt:
- Site 1040
-
-
-
-
-
Chihuahua City, Mexico, 31207
- Rekruttering
- Scientia Investigacion Clinica S.C.
-
Kontakt:
- Enrique Zamudio Lozoya, Site 0174
- Telefonnummer: 6146883416
-
-
DIF
-
Mexico City, DIF, Mexico, 03100
- Rekruttering
- CENEIT Oncologicos
-
Kontakt:
- Alberto Suarez Zaizar, Site 0177
- Telefonnummer: 525555342400
-
-
Estado de Baja California
-
Tijuana, Estado de Baja California, Mexico, 22010
- Ikke rekrutterer endnu
- Local Institution - 0264
-
Kontakt:
- Site 0264
-
-
Jalisco
-
Guadalajara, Jalisco, Mexico, 44680
- Ikke rekrutterer endnu
- Local Institution - 0178
-
Kontakt:
- Site 0178
-
-
Mexico City
-
Mexico City, Mexico City, Mexico, 14070
- Ikke rekrutterer endnu
- Local Institution - 0329
-
Kontakt:
- Site 0329
-
-
Nuevo León
-
Monterrey, Nuevo León, Mexico, 64320
- Ikke rekrutterer endnu
- Local Institution - 0175
-
Kontakt:
- Site 0175
-
Monterrey, Nuevo León, Mexico, 64460
- Ikke rekrutterer endnu
- Local Institution - 0176
-
Kontakt:
- Site 0176
-
Monterrey, Nuevo León, Mexico, 64460
- Trukket tilbage
- Local Institution - 0355
-
-
Oaxaca
-
Oaxaca City, Oaxaca, Mexico, 68020
- Ikke rekrutterer endnu
- Local Institution - 0173
-
Kontakt:
- Site 0173
-
-
Yucatán
-
Mérida, Yucatán, Mexico, 97000
- Ikke rekrutterer endnu
- Local Institution - 0179
-
Kontakt:
- Site 0179
-
-
-
-
Greater Poland Voivodeship
-
Skórzewo, Greater Poland Voivodeship, Polen, 60-185
- Aktiv, ikke rekrutterende
- Local Institution - 0189
-
-
Lublin Voivodeship
-
Biała Podlaska, Lublin Voivodeship, Polen, 21-500
- Trukket tilbage
- Local Institution - 0074
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Polen, 02-781
- Ikke rekrutterer endnu
- Local Institution - 0072
-
Kontakt:
- Site 0072
-
Warsaw, Masovian Voivodeship, Polen, 03-411
- Aktiv, ikke rekrutterende
- Local Institution - 0220
-
-
Opole Voivodeship
-
Opole, Opole Voivodeship, Polen, 45-061
- Ikke rekrutterer endnu
- Local Institution - 0076
-
Kontakt:
- Site 0076
-
-
Łódź Voivodeship
-
Lodz, Łódź Voivodeship, Polen, 93-338
- Aktiv, ikke rekrutterende
- Local Institution - 0221
-
-
-
-
-
Coimbra, Portugal, 3000-075
- Rekruttering
- Instituto Portugês de Oncologia de Coimbra Francisco Gentil
-
Kontakt:
- Gabriela Sousa, Site 0124
- Telefonnummer: +351239400200
-
Lisbon, Portugal, 1500-650
- Rekruttering
- Hospital da Luz Lisboa
-
Kontakt:
- Catarina Pulido, Site 0141
- Telefonnummer: +351917187738
-
Porto, Portugal, 4200-072
- Rekruttering
- Instituto Português de Oncologia do Porto Francisco Gentil, EPE
-
Kontakt:
- Cristina Oliveira, Site 0111
-
Porto, Portugal, 4200-319
- Rekruttering
- Centro Hospitalar de Sao Joao - Hospital de Sao Joao
-
Kontakt:
- Isabel Augusto, Site 0253
- Telefonnummer: +351963903409
-
-
Lisbon District
-
Lisbon, Lisbon District, Portugal, 1649-035
- Rekruttering
- Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa Maria
-
Kontakt:
- Luis Costa, Site 0109
- Telefonnummer: 351217805257
-
Lisbon, Lisbon District, Portugal, 1400-038
- Ikke rekrutterer endnu
- Local Institution - 0106
-
Kontakt:
- Site 0106
-
Lisbon, Lisbon District, Portugal, 1099-023
- Rekruttering
- Instituto Português de Oncologia de Lisboa Francisco Gentil
-
Kontakt:
- Patricia Pereira, Site 0198
-
-
-
-
-
Bucharest, Rumænien, 011171
- Aktiv, ikke rekrutterende
- Local Institution - 0083
-
Cluj-Napoca, Rumænien, 400015
- Aktiv, ikke rekrutterende
- Local Institution - 0077
-
Dumbrăviţa, Rumænien, 307160
- Afsluttet
- Local Institution - 0211
-
Iași, Rumænien, 700106
- Aktiv, ikke rekrutterende
- Local Institution - 0081
-
Iași, Rumænien, 700483
- Afsluttet
- Local Institution - 0080
-
Ploieşti, Rumænien, 100337
- Aktiv, ikke rekrutterende
- Local Institution - 0084
-
-
Bistrița-Năsăud County
-
Bistriţa, Bistrița-Năsăud County, Rumænien, 420020
- Ikke rekrutterer endnu
- Local Institution - 0212
-
Kontakt:
- Site 0212
-
-
Bucharest
-
Bucharest, Bucharest, Rumænien, 012292
- Afsluttet
- Local Institution - 0213
-
-
Cluj
-
Florești, Cluj, Rumænien, 407280
- Aktiv, ikke rekrutterende
- Local Institution - 0079
-
-
Dolj
-
Craiova, Dolj, Rumænien, 200746
- Afsluttet
- Local Institution - 0078
-
-
Timiș County
-
Timișoara, Timiș County, Rumænien, 300239
- Aktiv, ikke rekrutterende
- Local Institution - 0085
-
-
-
-
-
Zurich, Schweiz, 8008
- Aktiv, ikke rekrutterende
- Local Institution - 0251
-
-
Canton of St. Gallen
-
Sankt Gallen, Canton of St. Gallen, Schweiz, 9007
- Aktiv, ikke rekrutterende
- Local Institution - 0250
-
-
Canton of Vaud
-
Lausanne, Canton of Vaud, Schweiz, 1011
- Aktiv, ikke rekrutterende
- Local Institution - 0249
-
-
-
-
-
Madrid, Spanien, 28007
- Afsluttet
- Local Institution - 0107
-
Seville, Spanien, 41009
- Rekruttering
- Hospital Universitario Virgen Macarena
-
Kontakt:
- Luis de la Cruz Merino, Site 0103
- Telefonnummer: +34955926578
-
-
A Coruña [La Coruña]
-
A Coruña, A Coruña [La Coruña], Spanien, 15006
- Rekruttering
- CHUAC-Hospital Teresa Herrera
-
Kontakt:
- Silvia Antolin Novoa, Site 0105
- Telefonnummer: +34981178000
-
-
Alicante
-
Elche, Alicante, Spanien, 03203
- Rekruttering
- Hospital General Universitario de Elche
-
Kontakt:
- Álvaro Rodríguez-Lescure, Site 0100
- Telefonnummer: 111-111-1111
-
-
Barcelona [Barcelona]
-
Barcelona, Barcelona [Barcelona], Spanien, 08035
- Rekruttering
- Hospital Universitari Vall d'Hebron
-
Kontakt:
- Ana Mafalda Antunes de Melo e Oliveira, Site 0102
- Telefonnummer: 34934894158
-
Hospitalet, Barcelona [Barcelona], Spanien, 08907
- Afsluttet
- Local Institution - 0172
-
-
Catalunya [Cataluña]
-
Barcelona, Catalunya [Cataluña], Spanien, 08036
- Rekruttering
- Hospital Clínic de Barcelona
-
Kontakt:
- Marta González Rodríguez, Site 0140
- Telefonnummer: +34606895621
-
-
Gipuzkoa
-
Donostia / San Sebastian, Gipuzkoa, Spanien, 20014
- Rekruttering
- Hospital Universitario Donostia
-
Kontakt:
- Isabel Alvarez Lopez, Site 0139
- Telefonnummer: 34943006002
-
-
Madrid, Comunidad de
-
Madrid, Madrid, Comunidad de, Spanien, 28009
- Rekruttering
- Hospital General Universitario Gregorio Marañon
-
Kontakt:
- Sara Lopez Tarruella, Site 0104
- Telefonnummer: 34914269392
-
Madrid, Madrid, Comunidad de, Spanien, 28041
- Afsluttet
- Local Institution - 0108
-
-
Málaga
-
Málaga, Málaga, Spanien, 29010
- Rekruttering
- Hospital Universitario Virgen de la Victoria
-
Kontakt:
- Maria Emilia Dominguez Recio, Site 0101
- Telefonnummer: 34951291425
-
-
Valenciana, Comunitat
-
Valencia, Valenciana, Comunitat, Spanien, 46010
- Rekruttering
- Hospital Clinico de Valencia
-
Kontakt:
- Begona Bermejo de las Heras, Site 0210
- Telefonnummer: 34961973583
-
-
-
-
Skåne Län [se-12]
-
Malmö, Skåne Län [se-12], Sverige, 205 02
- Aktiv, ikke rekrutterende
- Local Institution - 0252
-
-
Stockholms Län [se-01]
-
Stockholm, Stockholms Län [se-01], Sverige, 112 19
- Aktiv, ikke rekrutterende
- Local Institution - 0026
-
-
Uppsala Län [se-03]
-
Uppsala, Uppsala Län [se-03], Sverige, 751 85
- Aktiv, ikke rekrutterende
- Local Institution - 0025
-
-
Örebro Län [se-18]
-
Örebro, Örebro Län [se-18], Sverige, 701 85
- Aktiv, ikke rekrutterende
- Local Institution - 0024
-
-
Östergötlands Län [se-05]
-
Linköping, Östergötlands Län [se-05], Sverige, 581 85
- Aktiv, ikke rekrutterende
- Local Institution - 0247
-
-
-
-
-
Johannesburg, Sydafrika, 2193
- Trukket tilbage
- Local Institution - 0342
-
Pretoria, Sydafrika, 0001
- Trukket tilbage
- Local Institution - 0336
-
Pretoria, Sydafrika, 0084
- Trukket tilbage
- Local Institution - 0341
-
Soweto, Sydafrika, 2013
- Trukket tilbage
- Local Institution - 0340
-
-
Eastern Cape
-
East London, Eastern Cape, Sydafrika, 5241
- Ikke rekrutterer endnu
- Local Institution - 0351
-
Kontakt:
- Site 0351
-
-
Western Cape
-
Cape Town, Western Cape, Sydafrika, 7570
- Trukket tilbage
- Local Institution - 1034
-
-
-
-
Kyǒnggi-do
-
Goyang-si, Kyǒnggi-do, Sydkorea, 10408
- Ikke rekrutterer endnu
- Local Institution - 0066
-
Kontakt:
- Site 0066
-
Seongnam, Kyǒnggi-do, Sydkorea, 13620
- Ikke rekrutterer endnu
- Local Institution - 0067
-
Kontakt:
- Site 0067
-
-
Seoul-teukbyeolsi [Seoul]
-
Seoul, Seoul-teukbyeolsi [Seoul], Sydkorea, 02841
- Ikke rekrutterer endnu
- Local Institution - 0068
-
Kontakt:
- Site 0068
-
Seoul, Seoul-teukbyeolsi [Seoul], Sydkorea, 03080
- Ikke rekrutterer endnu
- Local Institution - 0063
-
Kontakt:
- Site 0063
-
Seoul, Seoul-teukbyeolsi [Seoul], Sydkorea, 03722
- Ikke rekrutterer endnu
- Local Institution - 0071
-
Kontakt:
- Site 0071
-
Seoul, Seoul-teukbyeolsi [Seoul], Sydkorea, 05505
- Ikke rekrutterer endnu
- Local Institution - 0064
-
Kontakt:
- Site 0064
-
Seoul, Seoul-teukbyeolsi [Seoul], Sydkorea, 06351
- Ikke rekrutterer endnu
- Local Institution - 0065
-
Kontakt:
- Site 0065
-
-
Taegu-Kwangyǒkshi
-
Daegu, Taegu-Kwangyǒkshi, Sydkorea, 41404
- Ikke rekrutterer endnu
- Local Institution - 0069
-
Kontakt:
- Site 0069
-
-
-
-
-
Adana, Tyrkiet (Türkiye), 01123
- Ikke rekrutterer endnu
- Local Institution - 0361
-
Kontakt:
- Site 0361
-
Ankara, Tyrkiet (Türkiye), 06800
- Ikke rekrutterer endnu
- Local Institution - 0362
-
Kontakt:
- Site 0362
-
Istanbul, Tyrkiet (Türkiye), 34722
- Ikke rekrutterer endnu
- Local Institution - 0363
-
Kontakt:
- Site 0363
-
Istanbul, Tyrkiet (Türkiye), 34010
- Ikke rekrutterer endnu
- Local Institution - 0364
-
Kontakt:
- Site 0364
-
-
-
-
-
Berlin, Tyskland, 10117
- Aktiv, ikke rekrutterende
- Local Institution - 0261
-
Berlin, Tyskland, 10967
- Aktiv, ikke rekrutterende
- Local Institution - 0260
-
Bonn, Tyskland, 53111
- Aktiv, ikke rekrutterende
- Local Institution - 0259
-
Dresden, Tyskland, 01307
- Aktiv, ikke rekrutterende
- Local Institution - 0258
-
Heidelberg, Tyskland, D-69120
- Aktiv, ikke rekrutterende
- Local Institution - 0262
-
Ulm, Tyskland, 89081
- Aktiv, ikke rekrutterende
- Local Institution - 0291
-
-
Baden-Wurttemberg
-
Esslingen am Neckar, Baden-Wurttemberg, Tyskland, 73730
- Aktiv, ikke rekrutterende
- Local Institution - 0320
-
-
Bavaria
-
Augsburg, Bavaria, Tyskland, 86156
- Aktiv, ikke rekrutterende
- Local Institution - 0256
-
München, Bavaria, Tyskland, 80637
- Aktiv, ikke rekrutterende
- Local Institution - 0271
-
-
Hesse
-
Frankfurt am Main, Hesse, Tyskland, 60590
- Aktiv, ikke rekrutterende
- Local Institution - 0306
-
Langen, Hesse, Tyskland, 63225
- Aktiv, ikke rekrutterende
- Local Institution - 0333
-
-
Lower Saxony
-
Hanover, Lower Saxony, Tyskland, 30625
- Aktiv, ikke rekrutterende
- Local Institution - 0257
-
-
North Rhine-Westphalia
-
Düsseldorf, North Rhine-Westphalia, Tyskland, 40235
- Afsluttet
- Local Institution - 0293
-
Essen, North Rhine-Westphalia, Tyskland, 45136
- Aktiv, ikke rekrutterende
- Local Institution - 0263
-
-
Saxony
-
Leipzig, Saxony, Tyskland, 04103
- Ikke rekrutterer endnu
- Local Institution - 0254
-
Kontakt:
- Site 0254
-
-
Schleswig-Holstein
-
Lübeck, Schleswig-Holstein, Tyskland, 23538
- Afsluttet
- Local Institution - 0255
-
-
-
-
-
Salzburg, Østrig, 5020
- Aktiv, ikke rekrutterende
- Local Institution - 0267
-
Sankt Pölten, Østrig, 3100
- Aktiv, ikke rekrutterende
- Local Institution - 0270
-
Vienna, Østrig, 1090
- Aktiv, ikke rekrutterende
- Local Institution - 0269
-
-
Styria
-
Graz, Styria, Østrig, 8036
- Aktiv, ikke rekrutterende
- Local Institution - 0292
-
-
Tyrol
-
Innsbruck, Tyrol, Østrig, 6020
- Aktiv, ikke rekrutterende
- Local Institution - 0268
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria
-
Histologically or cytologically confirmed and documented locally-advanced, recurrent inoperable, or metastatic triple-negative breast cancer (TNBC) (ER < 1%, PgR < 1%, HER2 IHC 0, 1+, or 2+ with ISH negative for HER2 gene amplification) or ER-low, HER2-negative BC (ER and / or PgR 1% to 10%, HER2 IHC 0, 1+, or 2+ with ISH negative for HER2 gene amplification) per American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) criteria, based on the most recently analyzed biopsy or other pathology specimen.
-
Patients with recurrent disease must have experienced disease relapse at least 6 months after finishing their last therapy with curative intent.
-
Participants with TNBC must be considered ineligible for 1L chemotherapy combination treatment with an anti-PD-1 (eg, pembrolizumab) or an anti-PD-L1 (eg, atezolizumab) due to any one of the following criteria:
i) Investigator-determined ineligibility based on PD-L1 negative disease determined and documented prior to trial screening as part of standard of care (SoC); ii) Has experienced disease relapse between 6 to 12 months after the completion of (neo)adjuvant therapy with an anti-PD(L)1; iii) Has a severe auto-immune disease or other contraindication, in the opinion of the investigator, for the use of an anti-PD(L)1 drug: iv) Any auto-immune disease that requires current immunosuppression (eg, methotrexate, cyclophosphamide, prednisone > 10 mg/day).
v) Prior auto-immune AE to peri-adjuvant ICI that required immunosuppression. vi) Current Graves' disease with ophthalmopathy or in need of radioiodine or in use of antithyroid medication.
vii) Current or prior auto-immune diseases per below: A. Moderate to severe rheumatoid arthritis. B. Auto-immune hepatitis or cholangitis. C. Myasthenia gravis. D. Moderate-to-severe or poorly controlled inflammatory bowel disease. E. Multiple sclerosis. F. Lupus with kidney involvement or moderate to severe lupus. G. Auto-immune myocarditis. Note: if participant meets Inclusion Criteria 5b or 5c, unknown PDL1 results per local SOC are acceptable in these specific cases.
- Patients with ER-low, HER2-negative BC must be ineligible, in the opinion of the Investigator, for endocrine therapy-based treatments.
- No previous systemic therapy in the locally advanced, recurrent inoperable or metastatic setting (ie incurable setting).
- Measurable disease by CT or MRI as per RECIST v1.1.
Exclusion Criteria
-
Participants with a known germline breast cancer gene (BRCA) 1 or 2 mutation whose best 1L treatment option, in the opinion of the investigator, is a poli-ADP-ribose-polymerase inhibitors (PARPi).
-
Untreated symptomatic central nervous system (CNS) metastases. Participants are eligible if CNS metastases have been treated, and participants' neurological signs and symptoms have returned to baseline. In addition, participants must have been either off corticosteroids, or on a stable or decreasing dose of ≤ 10 mg daily prednisone (or equivalent) for at least 2 weeks prior to randomization. Imaging performed within 28 days of randomization must document radiographic stability of CNS lesions and be performed after completion of any CNS directed therapy.
-
Leptomeningeal metastases.
-
Participants with history of severe heart disease including, but not limited to, any of the following:
i) History of clinically significant heart disease (eg, cardiomyopathy, congestive heart failure with New York Heart Association functional classification II to IV, pericarditis, or significant pericardial effusion).
ii) Myocardial infarction, uncontrolled angina, or stroke/transient ischemic attack within the past 6 months.
iii) QTc (by Fridericia's formula) prolongation ≥ 450 msec for males and ≥ 470 msec for females, except for right bundle branch block.
iv) Known LVEF < 50%.
- Prior therapy with iza-bren or any other ADC targeting EGFR and/or HER3 or containing a topoisomerase 1 inhibitor payload.
- Other protocol-defined Inclusion/Exclusion criteria apply.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Aktiv komparator: Arm B
|
Specified dose on specified days Specified dose on specified days Specified dose on specified days Specified dose on specified days Specified dose on specified days |
|
Eksperimentel: Arm A1
|
Specified dose on specified days
Andre navne:
|
|
Eksperimentel: Arm A2
|
Specified dose on specified days
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Recommended Phase 3 Dose (RP3D) of BMS-986507
Tidsramme: Approximately 13 months from first participant randomization in Phase 2
|
Approximately 13 months from first participant randomization in Phase 2
|
|
|
Progression-Free Survival (PFS)
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by blinded independent central review (BICR) |
Approximately 22 months from first participant randomization in Phase 3
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Overall Survival (OS)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with treatment-related Adverse Events (AEs)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with laboratory abnormalities
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with serious AEs (SAEs)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with AEs leading to treatment discontinuation, interruption, dose reduction or dose delay
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of deaths
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Objective Response (OR) per BICR
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Objective Response (OR) per Investigator
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Relative change in tumor size
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Disease control rate (DCR) per BICR
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Disease control rate (DCR) per Investigator
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Duration of Response (DOR) per BICR
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Duration of response (DOR) per Investigator
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Time to Response (TTR) per BICR
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Time to response (TTR) per Investigator
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Change from baseline in European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Change from baseline in EORTC Breast Cancer-specific Quality of Life Questionnaire (QLQ-BR23)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Functional Assessment of Chronic Illness Therapy item GP5 (FACIT GP5) score
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Change from baseline in European Quality of Life 5 Dimensions 5 Levels (EQ-5D-5L)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
PFS rate
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by BICR |
Approximately 22 months from first participant randomization in Phase 3
|
|
PFS rate
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by Investigator |
Approximately 22 months from first participant randomization in Phase 3
|
|
PFS
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Assessed by Investigator |
Approximately 22 months from first participant randomization in Phase 3
|
|
Time to subsequent treatment (TTST) per Investigator
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Defined as time from randomization to the start of subsequent therapy or death |
Approximately up to 47 months from first participant randomization in Phase 3
|
|
Progression-free survival after next line of treatment (PFS2)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Defined as the time from randomization to the date of investigator-defined documented disease progression after next line of treatment or death due to any cause, whichever comes first |
Approximately up to 47 months from first participant randomization in Phase 3
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Studieleder: Bristol-Myers Squibb, Bristol-Myers Squibb
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Neoplasmer efter sted
- Neoplasmer
- Hudsygdomme
- Brystsygdomme
- Hud- og bindevævssygdomme
- Brystneoplasmer
- Tredobbelt negative brystneoplasmer
- Organiske kemikalier
- Heterocykliske forbindelser, 1-ring
- Heterocykliske forbindelser
- Nukleinsyrer, nukleotider og nukleosider
- Kulbrinter
- Cycloparaffiner
- Kulbrinter, alicyklisk
- Kulbrinter, cyklisk
- Terpenes
- Koordinationskomplekser
- Taxoider
- Cyclodecanes
- Diterpenes
- Deoxycytidin
- Cytidin
- Pyrimidin -nukleosider
- Pyrimidiner
- Nukleosider
- Uracil
- Pyrimidinoner
- Deoxyribonucleosider
- Fluorouracil
- Capecitabin
- Gemcitabin
- Carboplatin
- Paclitaxel
- 130-nm albuminbundet paclitaxel
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- CA244-0008
- 2024-519871-24 (Anden identifikator: EU CTR)
- U1111-1316-1533 (Anden identifikator: WHO)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
IPD-delingstidsramme
See Plan Description
IPD-delingsadgangskriterier
See Plan Description
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- CSR
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .